Users Online: 1384 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 


RSACP wishes to inform that it shall be discontinuing the dispatch of print copy of JOACP to it's Life members. The print copy of JOACP will be posted only to those life members who send us a written confirmation for continuation of print copy.
Kindly email your affirmation for print copies to dranjugrewal@gmail.com preferably by 30th June 2019.

 

 
Table of Contents
LETTER TO EDITOR
Year : 2016  |  Volume : 32  |  Issue : 4  |  Page : 537-538

Hydatidiform mole with uncontrolled hyperthyroidism: An anesthetic challenge


Department of Anaesthesia and Intensive Care, PGIMER, Chandigarh, India

Date of Web Publication25-Nov-2016

Correspondence Address:
Nidhi Bhatia
Department of Anaesthesia and Intensive Care, PGIMER, Chandigarh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0970-9185.194769

Rights and Permissions

How to cite this article:
Bhatia N, Mitharwal SM. Hydatidiform mole with uncontrolled hyperthyroidism: An anesthetic challenge. J Anaesthesiol Clin Pharmacol 2016;32:537-8

How to cite this URL:
Bhatia N, Mitharwal SM. Hydatidiform mole with uncontrolled hyperthyroidism: An anesthetic challenge. J Anaesthesiol Clin Pharmacol [serial online] 2016 [cited 2019 Nov 16];32:537-8. Available from: http://www.joacp.org/text.asp?2016/32/4/537/194769

Sir,

Molar pregnancy, an uncommon complication of pregnancy, presents in 5% of cases with clinical hyperthyroidism [1] and rarely with severe thyrotoxicosis. This occurs as, the alpha subunit of human chorionic gonadatropin (hCG) is structurally similar to thyroid stimulating hormone (TSH).[1],[2] Continuation of pregnancy carries the risk of hemorrhage, preeclampsia, and pulmonary emboli. Patients at times present with uncontrolled bleeding per vaginum (P/V) and require emergency termination of pregnancy.

A 24-year-old 2nd gravida, 15-week pregnant woman was referred to our labor room with bleeding P/V. Her abdominal ultrasound showed large mixed cystic and hyperechoic areas, without any gestational sac. The patient's laboratory investigations revealed hemoglobin level of 7 g%, severely elevated beta-hCG (2,250,000 mIU/ml), and thyroid hormone (T3 −4.36 ng/ml, T4 −28 µg/dl) levels, with markedly decreased TSH (0.01 µIU/ml) levels. A diagnosis of hydatidiform mole (H-mole) with uncontrolled hyperthyroidism was made. The patient was started on tablets propranolol 40 mg OD, carbimazole 30 mg OD, amlodipine 5 mg OD, and was prepared for emergency suction evacuation. Her baseline vitals were a heart rate of 135 beats per minute, noninvasive blood pressure of 140/90 mm Hg, and SpO2 of 98%. Two 16 gauge intravenous cannulae were secured. Keeping the possibility of high risk of perioperative thyroid storm in mind, all emergency drugs and equipments were kept ready. Regional anesthesia was administered using 10 mg of bupivacaine with 25 µg fentanyl in the subarachnoid space. Injection phenylephrine was kept ready to counteract any episode of postspinal hypotension. She was sedated with 1 mg injection midazolam intravenously. The surgical procedure lasted for 45-50 min, during which time there was approximately 500 ml of blood loss, for which one unit of blood was transfused. Rest of the intraoperative course was uneventful.

Gestational trophoblastic diseases (GTDs) are neoplastic disorders arising from the trophoblastic epithelium of the placenta and can be categorized into H-mole, persistent invasive gestation trophoblastic neoplasia, choriocarcinoma, and placental site trophoblastic tumors.[3] The incidence of H-mole varies from 1 in 1200 to 1 in 2500. Each GTD produces a different quantity of beta hCG, with a progression in concentrations from the H-mole (least) to the placental site trophoblastic tumors (most). Complicating the diagnosis of this condition is the fact that the ultrasound detection rate is only 30-50%, and majority of H-moles appear as a missed or incomplete miscarriage.[3] Termination of pregnancy should be done if patients present with significant bleeding, thyrotoxicosis, or severe hypertension. Patients of H-mole with uncontrolled hyperthyroidism pose a challenge to the anesthesiologist, as there is not enough time available for optimizing patients' clinical condition, which generally requires a minimum of 3-4 weeks.[4] In such patients, the possibility of perioperative thyroid storm should be kept in mind. Further, hyperthyroidism may go undetected, since patients, with no past thyroid dysfunctional history, may present in emergencies, with no time available for getting the blood investigations done. The clinical picture may also be confusing as tachycardia in such patients could be due to both bleeding P/V as well as hyperthyroidism, thus requiring a high index of suspicion for diagnosis. Perioperatively, it is important to ensure hemodynamic stability. In literature, both regional and general anesthesia has been described for management of molar pregnancy.[4] General anesthesia is preferred in hypotensive patients, who are bleeding profusely. In stable patients, spinal anesthesia is preferable due its nontocolytic properties and safety in hyperthyroid patients.[5] We preferred to give regional anesthesia to our patient as we considered that the sympathetic block resulting from spinal anesthesia would be beneficial. Further, tocolytic effect of volatile agents can result in further blood loss.[1],[5] Postoperatively, patients need to be observed carefully, preferably in a high dependency unit for initial 24-48 h, as the incidence of thyroid storm is high in the perioperative period. Further, thyroid function tests and b-hCG values should be monitored regularly until levels return to normal, to exclude the persistence of trophoblastic tissue.

To conclude, a coordinated team approach and high index of clinical suspicion are essential in the successful management of H-mole with uncontrolled hyperthyroidism.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
Kurdi MS. Hydatidiform mole: A sour encounter with a grapy case. Indian J Anaesth 2011;55:171-3.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.
Matsumoto S, Shingu C, Hidaka S, Goto K, Hagiwara S, Iwasaka H, et al. Anesthetic management of a patient with hyperthyroidism due to hydatidiform mole. J Anesth 2009;23:594-6.  Back to cited text no. 2
    
3.
Royal College of Obstetricians and Gynaecologists. The Management of Gestational Trophoblastic Neoplasia. Guidelines No. 38. London: RCOG; 2004.  Back to cited text no. 3
    
4.
Khanna P, Kumar A, Dehran M. Gestational trophoblastic disease with hyperthyroidism: Anesthetic management. J Obstet Anaesth Crit Care 2012;2:31-3.  Back to cited text no. 4
  Medknow Journal  
5.
Nandini D, Sarita F, Uday A, Hemalata I. Hydatidiform mole with hyperthyroidism — Perioperative challenges. J Obstet Gynecol India 2009;59:356-7.  Back to cited text no. 5
    



This article has been cited by
1 Tirotoksikozlu Hidatidiform Molar Gebeligi Olan Hastada Spinal Anestezi Yönetimi
berrin Günaydin,Halis Özdemir,Zeynep Dilmen,Merih Bayram
TURKISH JOURNAL of CLINICS and LABORATORY. 2018; 9(2): 155
[Pubmed] | [DOI]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
   References

 Article Access Statistics
    Viewed1184    
    Printed15    
    Emailed0    
    PDF Downloaded208    
    Comments [Add]    
    Cited by others 1    

Recommend this journal